ALD2510 - Alderaan Biotechnology
Keytruda (pembrolizumab) - Merck (MSD)
https://www.abstractsonline.com/pp8/#!/10828/presentation/3132
 
Stéphane FATTORI1; Aude Le Roy2; Jemila Houacine2; Lucie Robert3; Riad Abes2; Laurent Gorvel1; Samuel Granjeaud4; Marie-Sarah Rouvière5; Amira Ben Amara5; Nicolas Boucherit5; Carole Tarpin6; Jihane Pakradouni7; Emmanuelle Charafe-Jauffret8; Julien Barrou8; Gilles Houvenaeghel8; Eric Lambaudie8; François Bertucci6; Philippe Rochigneux9; Anthony Gonçalves6; Arnaud Foussat10; Anne-Sophie Chrétien1; Daniel Olive11
 
Mar 14, 2023
 
Next